Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Medisorb Naltrexone Extension
NCT00156936Phase 3Terminated
- Sponsor
- Alkermes
- Start
- Aug 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of naltrexone in alcohol dependence, opioid use disorder (OUD), sponsored by Alkermes. Started Aug 2004; status: terminated.
02
Drugs
naltrexone
03
Conditions
alcohol dependenceopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00156936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156936.